Expert InterviewCPRX
Slingshot members are talking to an expert! The topic is:
Legal Alpha: Understanding the patent strength of Catalyst Pharmaceuticals’ Firdapse after Teva’s ANDA challenge
Executed on:Feb 7, 2023 2:00 PM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
- Graduated from Georgetown Law School, after which he clerked for a Federal Judge in Chicago. Tried a number of trial cases while practicing law.
- Previously worked at Millennium Management in New York as a Portfolio Manager specializing in event-driven trading involving companies impacted by litigation, policy matters, regulatory and legislative events, and intellectual property & patent disputes.
- Advised some of the world’s leading hedge funds on trading securities impacted by legal events and catalysts, including SAC, CR Intrinsic and Millennium.
Interview Goal
This conversation is a look at our new product Legal Alpha. This subscription service focuses on analyzing the strength of intellectual property protecting key Branded Drugs, Medical Devices, and other Healthcare innovations.
This conversations focuses on the Firdapse patents and timing of a generic entrant into the market after Catalyst disclosed an ANDA filing by Teva on January 23rd.
This conversations focuses on the Firdapse patents and timing of a generic entrant into the market after Catalyst disclosed an ANDA filing by Teva on January 23rd.